Expediting the drug approval process: An analysis of the FDA Modernization Act of 1997

被引:0
作者
Parver, DG [1 ]
机构
[1] American Univ, Washington Coll Law, Washington, DC 20016 USA
关键词
D O I
暂无
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
引用
收藏
页码:1249 / 1266
页数:18
相关论文
共 50 条
[21]   The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional [J].
Adashi, Eli Y. ;
O'Mahony, Daniel P. ;
Cohen, I. Glenn .
AMERICAN JOURNAL OF MEDICINE, 2023, 136 (09) :853-854
[22]   FDA and drug approval [J].
Faich, GA .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) :S24-S24
[23]   THE FDA APPROVAL PROCESS [J].
HOKE, F .
SCIENTIST, 1994, 8 (18) :6-6
[24]   Food and drug administration modernization act of 1997: Medical device provisions [J].
Pilot, LR ;
Waldmann, DR .
FOOD AND DRUG LAW JOURNAL, 1998, 53 (02) :267-295
[25]   The US Food and Drug Administration Modernization Act of 1997: Impact on consumers [J].
Golodner, LF .
CLINICAL THERAPEUTICS, 1998, 20 :C20-C25
[26]   The Effects of the Prescription Drug User Fee Act and the Food and Drug Administration Modernization Act on the Development and Approval of Therapeutic Medicines [J].
Janice M. Reichert ;
Jennifer Chee ;
Claire S. Kotzampaltiris .
Drug information journal : DIJ / Drug Information Association, 2001, 35 (1) :85-94
[27]   The effects of the Prescription Drug User Fee Act and the Food and Drug Administration Modernization Act on the development and approval of therapeutic medicines [J].
Reichert, JM ;
Chee, J ;
Kotzampaltiris, CS .
DRUG INFORMATION JOURNAL, 2001, 35 (01) :85-94
[28]   Deterring fraud: Mandatory disclosure and the FDA drug approval process [J].
Sukhatme, Liora .
NEW YORK UNIVERSITY LAW REVIEW, 2007, 82 (04) :1210-1242
[29]   DRUG APPROVAL PROCESS - MIXED REVIEWS FOR FDA REFORM PLANS [J].
EMBER, L .
CHEMICAL & ENGINEERING NEWS, 1991, 69 (47) :4-5
[30]   FDA Primer: I. the drug and biologic approval process [J].
Mackler, B. F. ;
Landa, M. M. ;
Gamerman, G. E. .
Biotechnology and Applied Biochemistry, 1996, 23 (03)